Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice

Yandi Tan,1,* Shiqi Yang,1,* Yao Ma,2 Jinlin Li,1 Qian Xie,1 Chaoqi Liu,1 Yun Zhao1 1Medical College of China Three Gorges University, Yichang, Hubei, People’s Republic of China; 2Department of Ultrasonography, Yichang Central People’s Hospital, Yichang, People’s Republ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tan Y, Yang S, Ma Y, Li J, Xie Q, Liu C, Zhao Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/71ef56ba16654002b65f092fc7cf4d83
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:71ef56ba16654002b65f092fc7cf4d83
record_format dspace
spelling oai:doaj.org-article:71ef56ba16654002b65f092fc7cf4d832021-12-02T15:00:14ZNanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice1178-2013https://doaj.org/article/71ef56ba16654002b65f092fc7cf4d832021-05-01T00:00:00Zhttps://www.dovepress.com/nanobubbles-containing-spd-1-and-ce6-mediate-combination-immunotherapy-peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Yandi Tan,1,* Shiqi Yang,1,* Yao Ma,2 Jinlin Li,1 Qian Xie,1 Chaoqi Liu,1 Yun Zhao1 1Medical College of China Three Gorges University, Yichang, Hubei, People’s Republic of China; 2Department of Ultrasonography, Yichang Central People’s Hospital, Yichang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yun Zhao; Chaoqi LiuMedical College of China Three Gorges University, Yichang, Hubei, 443000, People’s Republic of ChinaEmail zhaoyun@ctgu.edu.cn; ctgulcq@163.comPurpose: Immune checkpoint inhibitors (ICIs) and sonodynamic therapy (SDT) are types of immunotherapy. In order to combine soluble programmed cell death protein 1 (sPD-1)-mediated immune checkpoint therapy and chlorin e6 (Ce6)-assisted SDT, nanobubbles (NBs) were generated to simultaneously load sPD-1 and Ce6.Materials and Methods: The sPD-1/Ce6-NBs, which were prepared by thin-film hydration and mechanical oscillation, had a stable physical condition, and delivered sPD-1 and Ce6 in a targeted manner. NBs could strengthen tumor suppression by increasing tumor-targeting accumulation of Ce6 and sPD-1, and by inducing ultrasound-targeted NB destruction. A mouse H22 cell hepatoma xenograft model was used to evaluate the synergetic immunotherapeutic effect and mechanism of sPD-1/Ce6-NBs.Results: By observing the tumor inhibition rate, tissue and cell apoptosis, apoptosis-related genes and protein expression, the best immunotherapeutic effect was exhibited by the sPD-1/Ce6-NBs group. The immunotherapeutic mechanism initially demonstrated that when tumor cells were transfected by sPD-1 delivered by NBs, which downregulated the expression of programmed death-ligand 1 (PD-L1) in tumor cells, and blocked the PD-1/PD-L1 signaling pathway, which improved T-cell-mediated tumor inhibition. Furthermore, ICIs combined with SDT induced immunogenic cell death by translocating calreticulin to the cell surface and then synergistically enhancing antitumor immune responses.Conclusion: In conclusion, sPD-1/Ce6-NBs were successfully designed. Ultrasound-mediated sPD-1/Ce6-NBs are potentially effective delivery systems for combination immunotherapy of hepatocellular carcinoma.Keywords: immune checkpoint inhibitors, ultrasonics, drug delivery, tumor therapy, nanomaterialsTan YYang SMa YLi JXie QLiu CZhao YDove Medical Pressarticleimmune checkpoint inhibitorsultrasonicsdrug deliverytumor therapynanomaterialsMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 3241-3254 (2021)
institution DOAJ
collection DOAJ
language EN
topic immune checkpoint inhibitors
ultrasonics
drug delivery
tumor therapy
nanomaterials
Medicine (General)
R5-920
spellingShingle immune checkpoint inhibitors
ultrasonics
drug delivery
tumor therapy
nanomaterials
Medicine (General)
R5-920
Tan Y
Yang S
Ma Y
Li J
Xie Q
Liu C
Zhao Y
Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice
description Yandi Tan,1,* Shiqi Yang,1,* Yao Ma,2 Jinlin Li,1 Qian Xie,1 Chaoqi Liu,1 Yun Zhao1 1Medical College of China Three Gorges University, Yichang, Hubei, People’s Republic of China; 2Department of Ultrasonography, Yichang Central People’s Hospital, Yichang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yun Zhao; Chaoqi LiuMedical College of China Three Gorges University, Yichang, Hubei, 443000, People’s Republic of ChinaEmail zhaoyun@ctgu.edu.cn; ctgulcq@163.comPurpose: Immune checkpoint inhibitors (ICIs) and sonodynamic therapy (SDT) are types of immunotherapy. In order to combine soluble programmed cell death protein 1 (sPD-1)-mediated immune checkpoint therapy and chlorin e6 (Ce6)-assisted SDT, nanobubbles (NBs) were generated to simultaneously load sPD-1 and Ce6.Materials and Methods: The sPD-1/Ce6-NBs, which were prepared by thin-film hydration and mechanical oscillation, had a stable physical condition, and delivered sPD-1 and Ce6 in a targeted manner. NBs could strengthen tumor suppression by increasing tumor-targeting accumulation of Ce6 and sPD-1, and by inducing ultrasound-targeted NB destruction. A mouse H22 cell hepatoma xenograft model was used to evaluate the synergetic immunotherapeutic effect and mechanism of sPD-1/Ce6-NBs.Results: By observing the tumor inhibition rate, tissue and cell apoptosis, apoptosis-related genes and protein expression, the best immunotherapeutic effect was exhibited by the sPD-1/Ce6-NBs group. The immunotherapeutic mechanism initially demonstrated that when tumor cells were transfected by sPD-1 delivered by NBs, which downregulated the expression of programmed death-ligand 1 (PD-L1) in tumor cells, and blocked the PD-1/PD-L1 signaling pathway, which improved T-cell-mediated tumor inhibition. Furthermore, ICIs combined with SDT induced immunogenic cell death by translocating calreticulin to the cell surface and then synergistically enhancing antitumor immune responses.Conclusion: In conclusion, sPD-1/Ce6-NBs were successfully designed. Ultrasound-mediated sPD-1/Ce6-NBs are potentially effective delivery systems for combination immunotherapy of hepatocellular carcinoma.Keywords: immune checkpoint inhibitors, ultrasonics, drug delivery, tumor therapy, nanomaterials
format article
author Tan Y
Yang S
Ma Y
Li J
Xie Q
Liu C
Zhao Y
author_facet Tan Y
Yang S
Ma Y
Li J
Xie Q
Liu C
Zhao Y
author_sort Tan Y
title Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice
title_short Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice
title_full Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice
title_fullStr Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice
title_full_unstemmed Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice
title_sort nanobubbles containing spd-1 and ce6 mediate combination immunotherapy and suppress hepatocellular carcinoma in mice
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/71ef56ba16654002b65f092fc7cf4d83
work_keys_str_mv AT tany nanobubblescontainingspd1andce6mediatecombinationimmunotherapyandsuppresshepatocellularcarcinomainmice
AT yangs nanobubblescontainingspd1andce6mediatecombinationimmunotherapyandsuppresshepatocellularcarcinomainmice
AT may nanobubblescontainingspd1andce6mediatecombinationimmunotherapyandsuppresshepatocellularcarcinomainmice
AT lij nanobubblescontainingspd1andce6mediatecombinationimmunotherapyandsuppresshepatocellularcarcinomainmice
AT xieq nanobubblescontainingspd1andce6mediatecombinationimmunotherapyandsuppresshepatocellularcarcinomainmice
AT liuc nanobubblescontainingspd1andce6mediatecombinationimmunotherapyandsuppresshepatocellularcarcinomainmice
AT zhaoy nanobubblescontainingspd1andce6mediatecombinationimmunotherapyandsuppresshepatocellularcarcinomainmice
_version_ 1718389207880171520